Jeffrey Stevens, CEO & Director of Psyched Wellness (CSE: PSYC) joins us in today’s episode of the Daily Dive. Jeff The post Psyched Wellness Attracts...
Company pumps the brakes on KetaMD. The post Braxia Reports Increased Clinic Treatments appeared first on Green Market Report.
Canadian-based psychedelics company Nirvana Life Sciences (CSE: NIRV) has decided to acquire Medsmart Dispensary Inc., which has an exclusive North American...
AGN Neuro plans to publish the data from the study in an upcoming issue of a peer-reviewed paper The post Algernon Pharmaceuticals completes final dosing...
Algernon Pharmaceuticals Inc. (CSE: AGN) (OTCQB: AGNPF)announced that its subsidiary Algernon NeuroScience (AGN Neuro), has successfully completed dosing...
The company is collaborating with Harvard Medical School and Massachusetts General Hospital for the trial. The post Tryp Therapeutics Advances Psilocybin...
MindBio Therapeutics Ethics Approval for Landmark World First Phase 2 Clinical Trial of Take-Home LSD-Microdosing for Major Depressive Disorder The post...
VANCOUVER – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) , an end-to-end drug researcher and formulator licensed by Health Canada to...
Natural products include probiotics, herbal remedies, vitamins and minerals, homeopathic medicines, traditional medicines among others The post Optimi...
In preclinical models, Lucid-MS has been shown to prevent a hallmark pathology feature of MS. The post FSD Pharma Makes Progress with MS Study appeared...